Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials
Published Online: 2021-07-07
Journal: Annals of HematologyLoading...
Authors: Andreas Hochhaus•Antje Schulze•Axel Florschütz•Christian Junghanss•Christian Späth•Christoph Kahl•Detlev Hähling•Dietger Niederwieser•Georg Maschmeyer•Haifa Kathrin Al-Ali•Hans-Heinrich Wolf•Herbert G. Sayer•Kolja Reifenrath•Michael Cross•Niklas Zojer•Norma Peter•Rainer Krahl•Sebastian Scholl•Thomas Fischer•Thomas Heinicke•Ute Hegenbart•Volker Schmidt
